These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 27124047

  • 1. Use of Electrocardiography to Predict Future Development of Hypertension in the General Population.
    Takase H, Sugiura T, Murai S, Yamashita S, Ohte N, Dohi Y.
    Medicine (Baltimore); 2016 Apr; 95(17):e3483. PubMed ID: 27124047
    [Abstract] [Full Text] [Related]

  • 2. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Apr; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 3. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161
    [Abstract] [Full Text] [Related]

  • 4. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN, Devereux RB, Okin PM.
    J Electrocardiol; 2014 Nov 17; 47(5):630-5. PubMed ID: 25052475
    [Abstract] [Full Text] [Related]

  • 5. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May 17; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 6. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlöf B.
    Hypertension; 2000 Nov 17; 36(5):766-73. PubMed ID: 11082141
    [Abstract] [Full Text] [Related]

  • 7. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B, LIFE Study Group.
    Hypertension; 2000 Jan 17; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [Abstract] [Full Text] [Related]

  • 8. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES.
    Am Heart J; 2010 May 17; 159(5):833-40. PubMed ID: 20435193
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
    Porthan K, Kenttä T, Niiranen TJ, Nieminen MS, Oikarinen L, Viitasalo M, Hernesniemi J, Jula AM, Salomaa V, Huikuri HV, Albert CM, Tikkanen JT.
    Int J Cardiol; 2019 Feb 01; 276():125-129. PubMed ID: 30293667
    [Abstract] [Full Text] [Related]

  • 12. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
    Agarwal R, Light RP.
    Clin J Am Soc Nephrol; 2011 Mar 01; 6(3):528-36. PubMed ID: 21088286
    [Abstract] [Full Text] [Related]

  • 13. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 14. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
    Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Hille DA, Dahlöf B.
    JAMA; 2006 Sep 13; 296(10):1242-8. PubMed ID: 16968848
    [Abstract] [Full Text] [Related]

  • 15. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 Sep 13; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 16. Accuracy of the novel Peguero Lo-Presti criterion for electrocardiographic detection of left ventricular hypertrophy in a black African population.
    Nyaga UF, Boombhi J, Menanga A, Mokube M, Ndomo Mevoula CS, Kingue S, Noubiap JJ.
    J Clin Hypertens (Greenwich); 2021 Jun 13; 23(6):1186-1193. PubMed ID: 33783138
    [Abstract] [Full Text] [Related]

  • 17. Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population.
    Ishikawa J, Ishikawa S, Kabutoya T, Gotoh T, Kayaba K, Schwartz JE, Pickering TG, Shimada K, Kario K, Jichi Medical School Cohort Study Investigators Group.
    Hypertension; 2009 Jan 13; 53(1):28-34. PubMed ID: 19015402
    [Abstract] [Full Text] [Related]

  • 18. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.
    Okin PM, Hille DA, Kjeldsen SE, Devereux RB.
    J Am Heart Assoc; 2017 Nov 18; 6(11):. PubMed ID: 29151037
    [Abstract] [Full Text] [Related]

  • 19. Prediction of stroke with electrocardiographic left ventricular hypertrophy in hypertensive patients: A meta-analysis.
    Yi S, Wang F, Wan M, Yi X, Zhang Y, Sun S.
    J Electrocardiol; 2020 Nov 18; 61():27-31. PubMed ID: 32504899
    [Abstract] [Full Text] [Related]

  • 20. Peguero-Lo Presti criteria for the diagnosis of left ventricular hypertrophy: A systematic review and meta-analysis.
    Yu Z, Song J, Cheng L, Li S, Lu Q, Zhang Y, Lin X, Liu D.
    PLoS One; 2021 Nov 18; 16(1):e0246305. PubMed ID: 33513186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.